Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of Promiscuous African Swine Fever Virus T-Cell Determinants Using a Multiple Technical Approach

  • Bosch-Camós, Laia
  • López, Elisabeth
  • Navas, María Jesús
  • Pina-Pedrero, Sonia
  • Accensi, Francesc
  • Correa-Fiz, Florencia
  • Park, Chankyu
  • Carrascal, Montserrat
  • Domínguez, Javier
  • Salas Falgueras, María Luisa
  • Nikolin, Veljko
  • Collado, Javier
  • Rodríguez, Fernando
The development of subunit vaccines against African swine fever (ASF) is mainly hindered by the lack of knowledge regarding the specific ASF virus (ASFV) antigens involved in protection. As a good example, the identity of ASFV-specific CD8<sup>+</sup> T-cell determinants remains largely unknown, despite their protective role being established a long time ago. Aiming to identify them, we implemented the IFNγ ELISpot as readout assay, using as effector cells peripheral blood mononuclear cells (PBMCs) from pigs surviving experimental challenge with Georgia2007/1. As stimuli for the ELISpot, ASFV-specific peptides or full-length proteins identified by three complementary strategies were used. In silico prediction of specific CD8<sup>+</sup> T-cell epitopes allowed identifying a 19-mer peptide from MGF100-1L, as frequently recognized by surviving pigs. Complementarily, the repertoire of SLA I-bound peptides identified in ASFV-infected porcine alveolar macrophages (PAMs), allowed the characterization of five additional SLA I-restricted ASFV-specific epitopes. Finally, in vitro stimulation studies using fibroblasts transfected with plasmids encoding full-length ASFV proteins, led to the identification of MGF505-7R, A238L and MGF100-1L as promiscuously recognized antigens. Interestingly, each one of these proteins contain individual peptides recognized by surviving pigs. Identification of the same ASFV determinants by means of such different approaches reinforce the results presented here., This research was funded by Departament d’Economia i Coneixement de la Generalitat de Catalunya (Spain), grant number 2015 DI 037. Studies were co-financed by Boehringer Ingelheim Veterinary Research Center (BIVRC) GmbH & Co. KG, the Ministerio de Ciencia e Innovación of Spain (grant numbers AGL2016-78169-C2-1-R and PID2019-107616RB-I00) and Red de Investigación en Sanidad Animal (RISA)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification of Promiscuous African Swine Fever Virus T-Cell Determinants Using a Multiple Technical Approach

  • Bosch Camós, Laia|||0000-0001-6245-4284
  • Navas, María Jesús
  • Pina-Pedrero, Sonia|||0000-0001-5475-4770
  • Accensi Alemany, Francesc|||0000-0001-9068-0377
  • Correa-Fiz, Florencia|||0000-0002-9459-5871
  • Park, Chankyu
  • Carrascal Pérez, Montserrat|||0000-0002-0205-2176
  • Domínguez, Javier|||0000-0001-7256-388X
  • Salas, María Luisa
  • Nikolin, Veljko
  • Collado Miguens, Javier Alonso|||0000-0002-6199-231X
  • Rodriguez, Fernando|||0000-0001-7361-8408
  • López Fernandez, Elisabet|||0000-0003-4253-330X
The development of subunit vaccines against African swine fever (ASF) is mainly hindered by the lack of knowledge regarding the specific ASF virus (ASFV) antigens involved in protection. As a good example, the identity of ASFV-specific CD8+ T-cell determinants remains largely unknown, despite their protective role being established a long time ago. Aiming to identify them, we implemented the IFNγ ELISpot as readout assay, using as effector cells peripheral blood mononuclear cells (PBMCs) from pigs surviving experimental challenge with Georgia2007/1. As stimuli for the ELISpot, ASFV-specific peptides or full-length proteins identified by three complementary strategies were used. In silico prediction of specific CD8+ T-cell epitopes allowed identifying a 19-mer peptide from MGF100-1L, as frequently recognized by surviving pigs. Complementarily, the repertoire of SLA I-bound peptides identified in ASFV-infected porcine alveolar macrophages (PAMs), allowed the characterization of five additional SLA I-restricted ASFV-specific epitopes. Finally, in vitro stimulation studies using fibroblasts transfected with plasmids encoding full-length ASFV proteins, led to the identification of MGF505-7R, A238L and MGF100-1L as promiscuously recognized antigens. Interestingly, each one of these proteins contain individual peptides recognized by surviving pigs. Identification of the same ASFV determinants by means of such different approaches reinforce the results presented here.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

M448R and MGF505-7R, Two African Swine Fever Virus Antigens Commonly Recognized by ASFV-Specific T-Cells and with Protective Potential

  • Bosch Camós, Laia|||0000-0001-6245-4284
  • López Fernandez, Elisabet|||0000-0003-4253-330X
  • Collado Miguens, Javier Alonso|||0000-0002-6199-231X
  • Navas, María Jesús
  • Blanco-Fuertes, Miguel|||0000-0002-8251-0682
  • Pina-Pedrero, Sonia|||0000-0001-5475-4770
  • Accensi Alemany, Francesc|||0000-0001-9068-0377
  • Salas, Maria Luisa
  • Mundt, Egbert
  • Nikolin, Veljko
  • Rodriguez, Fernando|||0000-0001-7361-8408
African swine fever (ASF) is today's number one threat for the global swine industry. Neither commercial vaccine nor treatment is available against ASF and, thus far, only live attenuated viruses (LAV) have provided robust protection against lethal ASF virus (ASFV) challenge infections. Identification of ASFV proteins inducing protective immune responses is one of the major challenges to develop safer and efficient subunit vaccines. Immunopeptidomic studies recently performed in our laboratory allowed identifying ASFV antigens recognized by ASFV-specific CD8 + T-cells. Here, we used data from the SLAI-peptide repertoire presented by a single set of ASFV-infected porcine alveolar macrophages to generate a complex DNA vaccine composed by 15 plasmids encoding the individual peptide-bearing ORFs. DNA vaccine priming improved the protection afforded by a suboptimal dose of the BA71ΔCD2 LAV given as booster vaccination, against Georgia2007/1 lethal challenge. Interestingly, M448R was the only protein promiscuously recognized by the induced ASFV-specific T-cells. Furthermore, priming pigs with DNA plasmids encoding M488R and MGF505-7R, a CD8 + T-cell antigen previously described, confirmed these two proteins as T-cell antigens with protective potential. These studies might be useful to pave the road for designing safe and more efficient vaccine formulations in the future.